贲门失弛缓症精准医学研究(PREMEDIA) (PREMEDIA)
精准医疗在贲门失弛缓症中的应用 - 非痉挛性贲门失弛缓症短程定制POEM与标准POEM的多中心随机非劣效性临床试验及痉挛性食管动力障碍长程定制POEM的多中心前瞻性队列研究
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:
- Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
- Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
研究概览
地位
详细说明
The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.
Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.
Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.
研究类型
注册 (估计的)
阶段
- 第三阶段
联系人和位置
学习联系方式
- 姓名:Elizabeth Yan, BS
- 电话号码:312-908-1723
- 邮箱:premedia.dcc@northwestern.edu
研究联系人备份
- 姓名:Yasmin Pina, BS
- 电话号码:312-503-6459
- 邮箱:premedia.dcc@northwestern.edu
学习地点
-
-
Arizona
-
Scottsdale、Arizona、美国、85259
- 尚未招聘
- Mayo Clinic Arizona
-
-
California
-
La Jolla、California、美国、92037
- 招聘中
- University of California San Diego
-
首席研究员:
- Rena Yadlapati, MD
-
接触:
- Alexander Gonsalves, Lead Study Coordinator
- 电话号码:858-246-5236
- 邮箱:PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver、Colorado、美国、80217
- 尚未招聘
- University of Colorado Denver
-
-
Florida
-
Gainesville、Florida、美国、32611
- 招聘中
- University of Florida
-
首席研究员:
- Peter Draganov, MD
-
接触:
- April Goddard, Lead Study Coordinator, PA-C
- 电话号码:352-273-9483
- 邮箱:DOM-GIResereachTeam@ad.ufl.edu
-
Orlando、Florida、美国、32803
- 尚未招聘
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta、Georgia、美国、30322
- 招聘中
- Emory University
-
首席研究员:
- Anand Jain, MD
-
接触:
- Halley Fowler, Lead Study Coordinator
- 电话号码:404-778-3184
- 邮箱:halley.fowler@emory.edu
-
-
Illinois
-
Chicago、Illinois、美国、60611
- 招聘中
- Northwestern University
-
首席研究员:
- John Pandolfino, MD
-
接触:
- Eric Pfannkuche, Lead Study Coordinator
- 电话号码:312-926-4525
- 邮箱:PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore、Maryland、美国、21218
- 尚未招聘
- Johns Hopkins University
-
-
Massachusetts
-
Boston、Massachusetts、美国、02114
- 招聘中
- Massachusetts General Hospital
-
接触:
- Madison Paylor, Lead Study Coordinator
- 电话号码:617-726-0196
- 邮箱:premedia@mgb.org
-
首席研究员:
- Kyle Staller, MD
-
-
Missouri
-
St Louis、Missouri、美国、63110
- 招聘中
- Washington University
-
接触:
- Darren Nix, Lead Study Coordinator
- 电话号码:314-273-1432
- 邮箱:Premediasurgerytrial@wustl.edu
-
首席研究员:
- Chandra Gyawali, MD
-
-
New York
-
New York、New York、美国、10065
- 尚未招聘
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte、North Carolina、美国、28204
- 招聘中
- Atrium Health/Wake Forest
-
首席研究员:
- Badih Elmunzer, MD
-
接触:
- Greg Scarola, Lead Study Coordinator
- 电话号码:(704) 355-2000
- 邮箱:PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland、Ohio、美国、44109
- 招聘中
- MetroHealth Medical Center
-
首席研究员:
- Ronnie Fass, MD
-
接触:
- Stephanie Baker, Lead Study Coordinator
- 电话号码:216-778-5736
- 邮箱:premedia@metrohealth.org
-
Cleveland、Ohio、美国、44106
- 尚未招聘
- Case Western Reserve University
-
-
Tennessee
-
Nashville、Tennessee、美国、37232
- 招聘中
- Vanderbilt University Medical Center
-
首席研究员:
- Dhyanesh Patel, MD
-
接触:
- Larry Raber, Lead Study Coordinator
- 电话号码:615-322-4643
- 邮箱:larry.w.raber@vumc.org
-
-
Texas
-
Dallas、Texas、美国、75246
- 招聘中
- Baylor Scott & White Health
-
接触:
- Neomy Flores, Lead Study Coordinator
- 电话号码:214-820-9704
- 邮箱:premedia@bswhealth.org
-
首席研究员:
- Vani Albertson Konda, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria
- Age ≥ 18
- Type I achalasia or type II achalasia or cEGJOO
- Eckardt score > 3
Exclusion Criteria
The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
- Weekly (or more frequent) opioid medication use in the last 2 years
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:标准肌切开术
|
Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
|
实验性的:个性化短肌切开术
|
Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Clinical Response-Overall
大体时间:From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
大体时间:From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
大体时间:From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
大体时间:From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.